Core Laboratories N.V. (CLB)
USD 18.21
(-4.86%)
USD 18.21
(-4.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.78 Million | 24.95 Million | 36.57 Million | 57.86 Million | 89.52 Million | 111.82 Million |
| Net Income | 36.67 Million | 19.65 Million | 20.21 Million | -96.92 Million | 93.7 Million | 79.78 Million |
| Depreciation & Amortization | 15.78 Million | 17.16 Million | 18.51 Million | 20.86 Million | 22.6 Million | 23.08 Million |
| Deferred income taxes | -10.81 Million | 433 Thousand | 6.01 Million | -12.21 Million | -36.34 Million | 1.83 Million |
| Stock-based compensation | 13.97 Million | 7.75 Million | 19.09 Million | 7.39 Million | 20.87 Million | 34.19 Million |
| Change in working capital | -28.77 Million | -9.56 Million | -11.5 Million | 35.05 Million | -10.84 Million | -9.89 Million |
| Other non-cash items | 71.95 Million | -10.48 Million | -15.76 Million | 103.69 Million | -478 Thousand | -17.18 Million |
| Investing Cash Flow | -6.65 Million | -3.85 Million | -10.22 Million | 7.85 Million | -5.67 Million | -70.63 Million |
| Investments in PPE | -10.57 Million | -10.21 Million | -13.53 Million | -11.88 Million | -22.26 Million | -21.74 Million |
| Acquisitions | 484.99 Thousand | 240 Thousand | 873 Thousand | 1.5 Million | 2.98 Million | -47.31 Million |
| Investment purchases | - | - | 13.53 Million | - | -1.88 Million | -1.27 Million |
| Sales/Maturities of investments | - | - | 726 Thousand | - | 22.26 Million | 22.93 Million |
| Other Investing Activities | 3.44 Million | 6.12 Million | -11.82 Million | 18.22 Million | -6.77 Million | -23.23 Million |
| Financing Cash Flow | -18.44 Million | -23.37 Million | -22.45 Million | -63 Million | -85.87 Million | -42.47 Million |
| Debt repayment | -10.25 Million | -15 Million | -71 Million | -102 Million | -123 Million | -114 Million |
| Dividends payments | -1.86 Million | -1.85 Million | -1.83 Million | -12.44 Million | -97.57 Million | -97.25 Million |
| Common Stock Repurchased | -2.2 Million | -3.9 Million | -8.25 Million | -2.79 Million | -3.3 Million | -7.45 Million |
| Common Stock Issuance | -4.06 Million | -411 Thousand | 59.13 Million | 56 Million | 137.99 Million | 178 Million |
| Other Financing Activities | -53.99 Thousand | -2.61 Million | 58.63 Million | -1.76 Million | 8000.00 | -1.77 Million |
| Accounts receivables | -2.61 Million | -10.07 Million | -13.52 Million | 46.42 Million | -3.19 Million | 2.26 Million |
| Accounts payables | -12.87 Million | 15.37 Million | 6.56 Million | -12.83 Million | -3.75 Million | -1.75 Million |
| Inventory | -12.97 Million | -14.86 Million | -4.54 Million | 1.47 Million | -3.89 Million | -10.4 Million |
| Other working capital | -299.99 Thousand | -15.45 Million | -12.75 Million | -29.11 Million | 3.13 Million | -19.1 Million |
| Cash at beginning of period | 15.42 Million | 17.7 Million | 13.8 Million | 11.09 Million | 13.11 Million | 14.4 Million |
| Cash at end of period | 15.11 Million | 15.42 Million | 17.7 Million | 13.8 Million | 11.09 Million | 13.11 Million |
| Capital Expenditure | -10.57 Million | -10.21 Million | -13.53 Million | -11.88 Million | -22.26 Million | -21.74 Million |
| Effect of forex changes on cash | -1.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -308 Thousand | -2.27 Million | 3.89 Million | 2.71 Million | -2.02 Million | -1.28 Million |
| Free Cash Flow | 14.21 Million | 14.74 Million | 23.04 Million | 45.98 Million | 67.25 Million | 90.08 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12 Million | 9.03 Million | 3.22 Million | 36.67 Million | 6.46 Million | 9.25 Million |
| Depreciation & Amortization | 3.67 Million | 3.77 Million | 3.84 Million | 15.78 Million | 3.87 Million | 3.92 Million |
| Deferred income taxes | 879 Thousand | -3.6 Million | 2.82 Million | -10.81 Million | 4.1 Million | -3.82 Million |
| Stock-based compensation | -475 Thousand | -132 Thousand | 4.82 Million | 13.97 Million | 1.56 Million | 2.06 Million |
| Change in working capital | -915 Thousand | 8.98 Million | -9.88 Million | -28.77 Million | 9.74 Million | -14.07 Million |
| Other non-cash items | -2.07 Million | 2.64 Million | 19.05 Million | 71.95 Million | 5.04 Million | 17.91 Million |
| Investing Cash Flow | -491 Thousand | -677.63 Thousand | -1.65 Million | -6.65 Million | -2.38 Million | -3.41 Million |
| Investments in PPE | -2.72 Million | -2.84 Million | -3.05 Million | -10.57 Million | -2.62 Million | -3.47 Million |
| Acquisitions | -797.79 Thousand | 204.79 Thousand | 593 Thousand | 484.99 Thousand | 59.61 Thousand | 67.29 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -491 Thousand | 1.95 Million | 805 Thousand | 3.44 Million | 26.16 Thousand | -1518.19 |
| Financing Cash Flow | -8.82 Million | -13.6 Million | -4.08 Million | -18.44 Million | -18.38 Million | -6.03 Million |
| Debt repayment | -8 Million | -12.91 Million | -3.01 Million | -10.25 Million | -16.23 Million | -4.03 Million |
| Dividends payments | -487.45 Thousand | -466.25 Thousand | -468 Thousand | -1.86 Million | -447.73 Thousand | -469.72 Thousand |
| Common Stock Repurchased | -196 Thousand | -161.17 Thousand | -44 Thousand | -2.2 Million | -1.76 Million | -219.37 Thousand |
| Common Stock Issuance | 591.62 Thousand | -42.62 Thousand | -549 Thousand | -4.06 Million | -1.18 Million | -289.79 Thousand |
| Other Financing Activities | -162 Thousand | -18.92 Thousand | -568 Thousand | -53.99 Thousand | 1.26 Million | -1.02 Million |
| Accounts receivables | -2.44 Million | -700.94 Thousand | -6.29 Million | -2.61 Million | -5.49 Million | 2.99 Million |
| Accounts payables | -3.48 Million | 3.65 Million | -551 Thousand | -12.87 Million | 378.96 Thousand | -4.44 Million |
| Inventory | 4.4 Million | 805.78 Thousand | 991 Thousand | -12.97 Million | 2.9 Million | -4.11 Million |
| Other working capital | 608 Thousand | 5.22 Million | -4.03 Million | -299.99 Thousand | 11.95 Million | -8.51 Million |
| Cash at beginning of period | 17.69 Million | 14.91 Million | 15.11 Million | 15.42 Million | 16.61 Million | 26.2 Million |
| Cash at end of period | 21.47 Million | 17.69 Million | 14.91 Million | 15.11 Million | 15.11 Million | 16.61 Million |
| Capital Expenditure | -2.72 Million | -2.84 Million | -3.05 Million | -10.57 Million | -2.62 Million | -3.47 Million |
| Effect of forex changes on cash | - | - | - | -1.00 | 6367.00 | 69.33 Thousand |
| Net cash flow / Change in cash | 3.77 Million | 2.78 Million | -206.99 Thousand | -308 Thousand | -1.49 Million | -9.58 Million |
| Free Cash Flow | 10.37 Million | 14.21 Million | 2.47 Million | 14.21 Million | 16.63 Million | -3.69 Million |
ACRV
300108
SMID
603166
6130
AGGG